» Articles » PMID: 11686099

Structure of Von Willebrand Factor and Its Function in Platelet Adhesion and Thrombus Formation

Overview
Publisher Elsevier
Specialty Hematology
Date 2001 Nov 1
PMID 11686099
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

The adhesive protein von Willebrand factor mediates the initiation and progression of thrombus formation at sites of vascular injury. von Willebrand factor is synthesized in endothelial cells and megakaryocytes as a very large polymer composed of identical subunits. In the plasma, it appears as a series of multimers of regularly decreasing molecular mass, from several thousand to 500 kDa. The size of circulating von Willebrand factor multimers is controlled by proteolytic cleavage carried out by a specific protease. The biological functions of von Willebrand factor are exerted through specific domains that interact with extracellular matrix components and cell membrane receptors to promote the initial tethering and adhesion of platelets to subendothelial surfaces, as well as platelet aggregation. Moreover, von Willebrand factor binds the procoagulant co-enzyme, factor VIII, contributing to its stability and, indirectly, to its function in the generation of fibrin. This chapter presents a review of current knowledge on the structure, biosynthesis and functions of von Willebrand factor.

Citing Articles

Clinical Utility of Recently Food and Drug Administration-Approved IntelliSep Test (Sepsis Biomarker) for Early Diagnosis of Sepsis: Comparison with Other Biomarkers.

Sarani N, Dasgupta A, Enders M, Rowan L, Elsarraj H, Gralnek S J Clin Med. 2024; 13(16).

PMID: 39200994 PMC: 11355800. DOI: 10.3390/jcm13164852.


Exploring ligands that target von Willebrand factor selectively under oxidizing conditions through docking and molecular dynamics simulations.

Interlandi G Proteins. 2024; 92(11):1261-1275.

PMID: 38829206 PMC: 11471382. DOI: 10.1002/prot.26706.


Knee replacement surgery in a patient with acquired von Willebrand disease: a case study with recommendations for patient management.

Alvarez Roman M, Rivas Pollmar M, De la Corte-Rodriguez H, Gomez-Cardero P, Rodriguez-Merchan E, Gutierrez-Alvarino M Ann Med Surg (Lond). 2024; 86(3):1681-1686.

PMID: 38463081 PMC: 10923270. DOI: 10.1097/MS9.0000000000001690.


Extracellular Vesicles in the Pathogenesis, Clinical Characterization, and Management of Dermatomyositis: A Narrative Review.

Ricco C, Eldaboush A, Liu M, Werth V Int J Mol Sci. 2024; 25(4).

PMID: 38396646 PMC: 10889219. DOI: 10.3390/ijms25041967.


Endothelial ADAM10 utilization defines a molecular pathway of vascular injury in mice with bacterial sepsis.

Alfano D, Miller M, Bubeck Wardenburg J J Clin Invest. 2023; 133(23).

PMID: 37788087 PMC: 10688991. DOI: 10.1172/JCI168450.